Aspirin for the Prevention of Recurrent Venous Thromboembolism (Q65543750)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Aspirin for the Prevention of Recurrent Venous Thromboembolism |
clinical trial |
Statements
Aspirin After Six Months or One Year of Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism in Patients With Idiopathic Venous Thromboembolism. The WARFASA Study. (English)
0 references
May 2004
0 references
January 2012
0 references
70
0 references
18 year
0 references